Form 4 Filing for Imunon, Inc. - Insider Transaction

This Form 4 filing details a transaction by Michael H. Tardugno, Executive Chairman of the Board of Imunon, Inc. On June 18, 2026, Tardugno acquired 4,629 shares of Common Stock, valued at $1.82 per share. This acquisition was made in lieu of cash for his base salary, as indicated by footnote F1. Following this transaction, Tardugno directly owns 17,467 shares. Additionally, he holds 4,622 shares indirectly through an IRA. The filing was signed on June 23, 2026, by Susan Eylward, acting as attorney-in-fact for Michael Tardugno.